Clinical Trial Update: Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with flutamide for recurrent or metastatic head and neck squamous cell carcinoma; currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• flutamide (flutamide)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING